ReviewCurrent medical science2023

Advances in Studies of Chiglitazar Sodium, a Novel PPAR Pan-Agonist, for the Treatment of Type 2 Diabetes Mellitus.

Xin-Hui Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.